← All trials
NCT07161843
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 30, 2025
- Primary completion
- Dec 30, 2026
- Completion date
- Feb 1, 2027
- First posted
- Sep 9, 2025
- Last posted
- Sep 9, 2025
- Enrollment
- 500
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Neukidney Inc.Lead sponsor
- Neukidney Inc.Sponsor investigator
Drugs studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.